3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Emergence Delirium
1
Interventions
Cyclophosphamide
29
fludarabine phosphate
19
Filgrastim
18
Whole-Body Irradiation
15
Mycophenolic Acid
15
Methotrexate
15
Peripheral Blood Stem Cell Transplantation
14
Cytarabine
14
Cyclosporine
13
Busulfan
12
Methylprednisolone
10
Thiotepa
9
Antilymphocyte Serum
9
Tacrolimus
8
Granulocyte Colony-Stimulating Factor
8
Clofarabine
8
Vincristine
7
Radiotherapy
7
Melphalan
7
Cord Blood Stem Cell Transplantation
7
fludarabine
6
Leucovorin
6
Dexamethasone
6
merphos
5
Mercaptopurine
5
Etoposide
5
Daunorubicin
5
Cladribine
5
Therapeutics
4
Prednisone
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Leukemia, Biphenotypic, Acute
×
Nalbuphine
×
Clear all
NCT03825887
2021-08-02
PCA
Children's Cancer Hospital Egypt 57357
Phase 3
Completed
80 enrolled